Skip to content

Hernia-Prophylaxis in Acute Care Surgery H-PACS

Prophylactic Mesh Implantation in Patients Undergoing Requiring Emergency Laparatomy for the Prevention of Incisional Hernia:A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03090022
Acronym
H-PACS
Enrollment
61
Registered
2017-03-24
Start date
2017-03-01
Completion date
2020-10-05
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incisional Hernia

Brief summary

Incisional hernia is a common complication in visceral surgery and varies between 11 and 26% in the general surgical population. Patients requiring emergency laparotomy are at high risk for the development of incisional hernia and fascial dehiscence. Among this population the incidence of incisional hernia in patients undergoing emergency surgery varies between 33-54%. Incisional hernias are associated with a high morbidity rate, such as intestinal incarceration, chronic discomfort, pain, and reoperation and typically require implantation of a synthetic mesh in a later second operation. Fascial dehiscence represents an acute form of dehiscence and has been observed in up to 24.1% and is associated with a mortality rate up to 44%. The gold standard for abdominal wall closure during elective and emergency operations is a running slowly absorbable suture. In the elective situation it has been shown that prophylactic mesh implantation in high risk patients reduced the incidence of incisional hernia significantly. The investigators and others have shown that mesh implantation in patients undergoing emergency laparotomy or in contaminated abdominal cavities are safe . With a randomized controlled trial the investigators now aim to compare the incidence of incisional hernia after prophylactic mesh implantation versus standard of care in patients requiring emergency laparotomy.

Interventions

PROCEDUREStrattice

Intra-abdominally Fixation

PROCEDURESingle running suture of abdominal fascia

Intra-abdominal suture

Sponsors

Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing emergency midline laparatomy * Emergency laparoscopy with expected conversion to midline laparatomy * Written informed consent

Exclusion criteria

* ASA ≥5 * Septic shock * Pregnant women * Prior mesh Implantation * Known sensitivity for porcine material or Polysorbate 20

Design outcomes

Primary

MeasureTime frameDescription
Number of incidence of deathup to 18 monthsfollow-up
Number of patients with hernia free survivalup to 18 monthsfollow-up

Secondary

MeasureTime frameDescription
Number of surgical site infections postoperative30 daysfollow-up
Number of postoperative intestinal fistulas30 daysfollow-up
Number of small bowel obstructions18 monthsfollow-up
Number of patients with postoperative fascial dehiscence30 daysfollow-up
Number of postoperative mesh infections18 monthsfollow-up
Number of postoperative mesh explantations18 monthsfollow-up
Number of patients with postoperative pain18 monthsfollow-up
Number of postoperative mortality90 dayssurvival

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026